Olanzapine use in women with antipsychotic-induced hyperprolactinemia

被引：17

作者：

Canuso, CM

Hanau, M

Jhamb, KK

Green, AI

机构：

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 1998年 / 155卷 / 10期

关键词：

D O I：

10.1176/ajp.155.10.1458

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：1458 / 1458

页数：1

共 4 条

[1] OSTEOPOROSIS AND SCHIZOPHRENIA - CAN WE LIMIT KNOWN RISK-FACTORS [J].

ABRAHAM, G ;

FRIEDMAN, RH ;

VERGHESE, C ;

DELEON, J .

BIOLOGICAL PSYCHIATRY, 1995, 38 (02) :131-132

[2] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].

Beasley, CM ;

Tollefson, G ;

Tran, P ;

Satterlee, W ;

Sanger, T ;

Hamilton, S ;

Fabre, L ;

Small, J ;

Ereshefsky, L ;

True, J ;

Nemeroff, C ;

Risch, SC ;

Perry, PJ ;

Potkin, SG ;

Borison, RL ;

James, S ;

Meltzer, HY ;

Iqbal, N ;

Fann, WE ;

Gewirtz, GR ;

Landbloom, R ;

RoyByrne, PP ;

Tuason, VB ;

Carman, JS ;

Stokes, PE ;

Williams, R ;

Ancill, RJ ;

MacEwan, GW ;

Gujavarty, KS ;

Jones, B ;

Lohr, JB .

NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123

[3] PROLACTIN AND NEUROLEPTIC DRUGS [J].

GREEN, AI ;

BROWN, WA .

NEUROLOGIC CLINICS, 1988, 6 (01) :213-223

[4]

SZYMANSKI S, 1995, AM J PSYCHIAT, V152, P698

← 1 →